Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ACE insertion deletion polymorphisms and effectiveness of statin therapy.

Atherosclerosis - 1 Feb 2005

Miltiadous George, Xenophontos Stavroula, Cariolou Marios, Elisaf Moses

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Coronary Disease
Share to Genetic Markers
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypercholesterolemia

Share to Peptidyl-Dipeptidase A

Share to Polymorphism, Genetic

Share to Treatment Outcome

Source

Identifiers

PMID: 15694952
DOI: 10.1016/j.atherosclerosis.2004.10.003

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACE insertion deletion polymorphisms and effectiveness of statin therapy.PMID 15694952Read ↗

Clinical implications of pharmacogenomics of statin treatmentSemantic proximity Read ↗

Pharmacogenetics: the outlook for genetic testing in statin therapy.Semantic proximity Read ↗

ACE polymorphism and COVID-19 outcomeSemantic proximity Read ↗

The pharmacogenomics of statins.Semantic proximity Read ↗

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?Semantic proximity Read ↗

COVID-19 infections are also affected by human ACE1 D/I polymorphismSemantic proximity Read ↗

Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseasesSemantic proximity Read ↗

[Polymorphisms in ACE gene deletion/insertion in type 2 diabetes].Semantic proximity Read ↗

Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition.Semantic proximity Read ↗

Statins and type 2 diabetes: genetic studies on target.Semantic proximity Read ↗

When the same treatment has different response: The role of pharmacogenomics in statin therapySemantic proximity Read ↗

Genetic determinants of response to statins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.